Magentiq Eye LTD develops the MAGENTIQ-COLO System, an AI-powered platform for automatic polyp detection and analysis during colonoscopy procedures. This technology enhances adenoma detection rates, significantly reducing the risk of colorectal cancer by improving diagnostic accuracy and clinical decision-making in gastroenterology.
Funding
Funding not disclosed
Founders
Product
Problem
Colorectal cancer is a leading cause of cancer-related deaths, and its prevention relies heavily on effective polyp detection during colonoscopies. Missed polyps during these procedures can lead to delayed diagnoses and increased risk of the disease.
Solution
Magentiq Eye's MAGENTIQ-COLO System is an AI-powered platform designed to enhance polyp detection and analysis during colonoscopies. By processing and analyzing colonoscopy video feeds in real-time, the system assists gastroenterologists in identifying potential adenomas and other lesions that might otherwise be missed. This leads to improved adenoma detection rates (ADR), a critical metric for reducing the incidence of colorectal cancer. The platform's advanced machine learning algorithms have been trained on a vast dataset of colonoscopy images, enabling it to provide accurate and reliable support for clinical decision-making.
Target Audience
The primary target audience includes gastroenterologists, endoscopy centers, and hospitals seeking to improve the accuracy and efficiency of colonoscopies and reduce the risk of colorectal cancer.
Features
- Real-time analysis of colonoscopy video feeds
- AI-powered detection and highlighting of potential polyps
- Calculation and display of key performance indicators, including adenoma detection rate (ADR)
- Integration with existing colonoscopy equipment and workflows
- Cloud-based platform for data storage and analysis
- Support for multiple endoscope brands
- Automatic software updates